NASDAQ
The Nasdaq-100 Index has announced its annual reconstitution, with six new companies being added and six being removed, effective December 22, 2025....
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has entered into separate, privately negotia...
Federated Hermes Inc. increased its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) by 22.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and...
Alnylam has been a big winner for investors since its IPO in 2004. The drugmaker's future looks promising....
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of tw...
Those four companies, culled from a list drawn up by KBW analyst Shreyank Gandhi, are among the largest not in the index....
Google's parent company received a relatively benign antitrust ruling that would not force Alphabet to sell its Chrome browser or Android operating system. Chipotle Mexican Grill reported mixed quarte...
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stock is trading higher on Friday, with no news to justify the movement....
The Virtus Silvant Mid-Cap Growth Fund returned +5.43% (Class INST) for the quarter, compared to the Russell Midcap Growth Index's return of +2.78%. Palantir Technologies (PLTR) and Roblox (RBLX) were...
The S&P 500's TJX is among the five stocks to watch showing resilience in a tough market...
No price data available for this timeframe.